1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Aurora Cannabis Inc.
  6. Summary
    ACB   CA05156X8843

AURORA CANNABIS INC.

(ACB)
  Report
Delayed Toronto Stock Exchange  -  04:00 2022-07-05 pm EDT
1.780 CAD   +5.33%
06/24Toronto index rebounds on tech, healthcare boost
RE
06/24Cantor Fitzgerald Upgrades Aurora Cannabis to Overweight From Neutral, Adjusts Price Target to CA$4.05 From CA$3.90
MT
06/24AURORA CANNABIS BRIEF : BNN TV Notes Cantor Fitzgerald Cites ACB's Potential Growth In Europe, Including Germany
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
06/28/2022 06/29/2022 06/30/2022 07/04/2022 07/05/2022 Date
1.93(c) 1.76(c) 1.7(c) 1.69(c) 1.78(c) Last
1 818 349 1 837 013 1 694 641 764 430 1 788 472 Volume
-3.98% -8.81% -3.41% -0.59% +5.33% Change
More quotes
Estimated financial data (e)
Sales 2022 223 M 171 M 171 M
Net income 2022 -932 M -713 M -713 M
Net cash position 2022 162 M 124 M 124 M
P/E ratio 2022 -0,34x
Yield 2022 -
Sales 2023 230 M 176 M 176 M
Net income 2023 -96,5 M -73,9 M -73,9 M
Net cash position 2023 108 M 82,5 M 82,5 M
P/E ratio 2023 -4,22x
Yield 2023 -
Capitalization 530 M 406 M 406 M
EV / Sales 2022 1,65x
EV / Sales 2023 1,83x
Nbr of Employees 1 761
Free-Float 99,8%
More Financials
Company
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution and sale of cannabis and cannabis related products in Canada and internationally. The Company's portfolio of brands includes Aurora, Aurora Drift, San Rafael '71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD. Its cannabis products are primarily... 
Sector
Pharmaceuticals
Calendar
09/27Earnings Release
More about the company
Ratings of Aurora Cannabis Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about AURORA CANNABIS INC.
06/24Toronto index rebounds on tech, healthcare boost
RE
06/24Cantor Fitzgerald Upgrades Aurora Cannabis to Overweight From Neutral, Adjusts Price Ta..
MT
06/24AURORA CANNABIS BRIEF : BNN TV Notes Cantor Fitzgerald Cites ACB's Potential Growth In Eur..
MT
06/24AURORA CANNABIS BRIEF : Cantor Fitzgerald Upgraded Co To Overweight From Neutral and Has a..
MT
06/22Aurora Cannabis to layoff 12% of workforce amid reorganization
AQ
06/09Toronto index falls for second day as energy shares slide
RE
06/06Stifel Upgrades Aurora Cannabis to Hold From Sell, Adjusts Price Target to CA$2.15 From..
MT
06/03Aurora Cannabis Repurchases $25 Million Of Convertible Notes
MT
06/03AURORA CANNABIS : Repurchases US$20 Million of Convertible Notes - Form 6-K
PU
06/03AURORA CANNABIS BRIEF : Repurchases US$20 Million of Convertible Notes
MT
06/03Aurora Cannabis Repurchases US$20 Million in Convertible Notes at Discount
DJ
06/02Aurora Cannabis Inc. - Closes Previously Announced Bought Deal Financing
AQ
06/02Toronto index gains as miners boost
RE
06/01AURORA CANNABIS : COMPUTERSHARE TRUST COMPANY OF CANADA WARRANT INDENTURE - Form 6-K
PU
06/01AURORA CANNABIS : Closes Previously Announced Bought Deal Financing Over-Allotment Option ..
PU
More news
News in other languages on AURORA CANNABIS INC.
05/27Aurora Cannabis augmente son financement par prise ferme ; baisse de 39,5 %.
05/27Aurora Cannabis augmente son financement par prise ferme ; baisse de 34,3 %.
05/17Les actions de Toronto affichent une troisième session consécutive de gains grâce à un ..
05/13L'indice de Toronto rebondit grâce à l'énergie et aux technologies
05/13PIPER SANDLER SUR AURORA CANNABIS : "Rentabilité à l'horizon"
More news
Analyst Recommendations on AURORA CANNABIS INC.
More recommendations
Chart AURORA CANNABIS INC.
Duration : Period :
Aurora Cannabis Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AURORA CANNABIS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 1,78 CAD
Average target price 3,40 CAD
Spread / Average Target 91,0%
EPS Revisions
Managers and Directors
Miguel Martin Director & Chief Commercial Officer
Glen W. Ibbott Chief Financial Officer
Ronald F. Funk Chairman
Darryl Vleeming Chief Information Officer
Adam Kelley Szweras Independent Director